Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Core EBITDA Growth

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023
   Core EBITDA Growth(%) 96.50-

What is the latest Core EBITDA Growth ratio of GENPHARMASEC ?

The latest Core EBITDA Growth ratio of GENPHARMASEC is 96.50 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202496.50
Mar2023-

How is Core EBITDA Growth of GENPHARMASEC Trending?

Years Core EBITDA Growth % Change
Mar2024 96.5
0
Mar2023 0 -

Other Financial Ratios of GENPHARMASEC


Compare Core EBITDA Growth ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹109.6 Cr -0.5% -0.5% -38.8% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹11,815.0 Cr 5.2% 9.9% 43.5% Stock Analytics
KIRI INDUSTRIES ₹3,162.6 Cr -0.1% -3.8% 45.8% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,894.9 Cr 3% -8.6% -19.6% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,037.6 Cr -6.6% -15.3% 24% Stock Analytics
BODAL CHEMICALS ₹809.1 Cr -4.9% -13.3% -18.7% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-0.5%

-0.5%

-38.8%

SENSEX

-2.2%

-1.7%

-1.2%


You may also like the below Video Courses